Clinical Trial Update: A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating SBRT after induction chemotherapy for locally advanced pancreatic cancer is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• SBRT (stereotactic body radiotherapy)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2022-10-13